BIIB vs RBC · P/E 21, rev $9.89B vs P/E 69, rev $1.87B
Biogen Inc (BIIB) versus RBC Bearings Incorporated (RBC) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
RBC Bearings Incorporated (RBC) is a tools & accessories company listed on NYSE.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported RBC revenue for 2026-03-28 was $1.87B. Net income was $287.6M. Revenue was up 14.3% from 2025-03-29 to 2026-03-28. RBC currently screens at market cap $19.80B and trailing P/E 69.0.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. RBC currently screens at market cap $19.80B and trailing P/E 69.0.
Not investment advice. Open the BIIB and RBC stock pages for the full models.
Not investment advice.